Introduction
The stimulation of cellular responses by hormones, neurotransmitters and growth factors requires the transmission of the signal from the exterior to the interior of the cell. This signal transduction involves the generation of second messenger molecules, resulting in the activation of highly regulated intracellular processes. The generation of second messengers proceeds through two distinct types of pathway: first, through a G-protein-linked activation of an effector, or secondly, through the stimulation of an intrinsic receptor tyrosine kinase. The proliferation of fibroblast cells in culture can be stimulated by both classes of agonist, with bombesin or lysophosphatidic acid (LPA) exemplifying the former, whilst platelet-derived growth factor (PLIGF) or epidermal growth factor (EGF) exemplify the latter. Mitogenic stimulation activates a range of signalling pathways, one of the early effects being phospholipid hydrolysis. The most extensively characterized pathway of phospholipid hydrolysis involves the phospholipase C (P1,C)-catalysed hydrolysis of phosphatidylinositol 4,s-bisphosphate (PtdlnsPJ to generate the two second messenger molecules, inositol 1,4,5-trisphosphate and sn-1,2-diacylglycerol (DAG), which stimulate an increase in intracellular free calcium concentration and in protein kinase C (PKC) activity respectively. However, there is now considerable evidence that PtdInsP, hydrolysis is rapidly desensitized and, indeed, may play only a minor role in certain physiological events such as mitogenesis.
In addition to inositol lipid hydrolysis, it is clear that phosphatidylcholine (PtdCho) is hydrolysed in response to a wide range of cellular stimuli (PLAJ. In considering these different activities, it is important to note that, whilst the cellular content of PtdInsP, is less than 1% of the total phospholipid of the cell, PtdCho makes up more than 40%. The PtdCho is unlikely to exist as a single pool and, indeed, is found in all cellular membranes, therefore it is unlikely that the three phospholipases hydrolyse the same PtdCho pool. It is also unclear if the phospholipases are functioning at the same cellular membrane. concentration is indeed responsible for the activation of PLD, there should be a leftward shift in the dose dependence of bombesin-stimulated phospholipase activation; there was, however, no effect [Z] .
Control of PLD activity
It has been suggested that there is a direct <:-protein input in the activation of PLD. This is unlikely, since there is a distinct lag of some 10-15 s before stimulation is observed in response to bombesin. Using streptolysin 0-permeabilized cells, it is possible to stimulate PI,D activity with the nonhydrolysable GTP analogue GTP yS and to inhibit bombesin-stimulated activity with an excess of the non-hydrolysable GDP analogue GDPPS. However, it is not possible to potentiate the response to bombesin with GTPyS nor vice versa, which would argue against a direct G-protein-mediated effect. Experiments where the cells were metabolically inhibited also suggested that there is an essential requirement for a kinase in the stimulation of PLD.
In fibroblasts it is possible to stimulate PLD activity with the tyrosine-kinase-activating agonists PDGF and EGF, the latter in the absence of stimulated inositol lipid hydrolysis. This raised the possibility that the enzyme is regulated by tyrosine phosphorylation. Activation of cytosolic tyrosine kinase activity can be observed in Swiss 3T3 cells and thus may play a key activating role. In formylMet-Leu-Phe-stimulated human neutrophils, inhibitors of tyrosine kinases completely inhibit stimulated PI,D activity [3] . In Swiss 3T3 cells, pervanadate, an inhibitor of tyrosine phosphatase activity, activates PLD; however, the inclusion of tyrosine kinase inhibitors has only a minor inhibitory effect on bombesin-stimulated activity. It thus appears that agonist-stimulated PLD activation can be mimicked by the activation of either or both of PKC and tyrosine kinases. It appears further that the contribution made by the two kinases is dependent on cell and/or agonist type. This raises the possibility of a PLD-activating protein(s) that is regulated by one or both of the two protein kinases. Such a postulated protein could be similar to mitogen-activated protein kinase, which has been shown to play such a role in the activation of PLA2 [ 41. Alternatively, there may be multiple isozymes of PLD that are subject to different modes of regulation by differing kinases.
Control of PLA, activity
PLA, exists in both low-and high-molecular-mass forms. The low-molecular-mass 'secretory' forms show no clear substrate selectivity and are not receptor-activated. The high-molecular-mass form has been demonstrated to be selective towards arachidonyl-containing PtdCho, and to be stimulated in cells [S] . This PLA, can be activated by both G-protein-linked and receptor tyrosine kinase agonists and also by treatment of cells with phorbol 12-myristate 13-acetate and the artificial elevation of intracellular Ca2+ concentration. These experiments suggested the existence of multiple forms of PLA,, however cDNA cloning studies showed the presence of only a single gene [S] . The explanation for this apparent paradox was provided by the demonstration that PLA, was a substrate for the 'switch kinase' mitogen-activated protein kinase [4] .
This observation explains the multiple mechanisms of PLA, activation, since they can all stimulate the activity of this protein kinase. PLA2 exists both in cytosolic and in membrane-bound forms. It was originally suggested that the translocation of the enzyme was mediated by Gal', however, it is more likely to be regulated by its phosphorylation state. Using an anti-peptide anti-PI,A2 antibody, we have been able to detect only the phosphorylated enzyme in a cellular membrane rather than a cytosolic fraction. Whether the enzyme is phosphorylated at the membrane or is translocated after phosphorylation in the cytosol remains to be determined.
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Control of PLC activity
PtdCho-PLC is a poorly characterized activity. This may be because the definitive demonstration of its activity in a stimulated cell is complicated by the rapid metabolism of its products and by there being a number of additional pathways that could give rise to the same class of compound. Nevertheless, there is increasing evidence that this activity is stimulated by a range of agonists, for example, by bombesin in Swiss 3T3 cells. Analyses of the watersoluble [.'H]choline metabolites from bombesinstimulated pre-labelled cells shows rapid choline generation, with later, but more sustained, choline phosphate generation. Whilst clearly choline phosphate can be derived from choline through the action of choline kinase, we have now shown that stimulated PIL) activity is rapidly desensitized.
Therefore, it is probable that the choline phosphate is generated by a PIX-catalysed reaction. Support for this possibility is provided by the analysis of DAG molecular species. In cells stimulated for short (25 s) periods we find that the acyl chain structure of the DAG generated is very similar to that found in the inositol phospholipids. After S or 30 min, however, the DAG acyl chain structure is more like that detected in PtdCho [6] . In addition, inclusion of 30 mM butanol does not decrease the generation of the PtdCho-like DAG species significantly at these later time points. Therefore, the DAG appears to be PtdCho-derived but not produced through a PI,D/phosphatidate phosphohydrolase pathway, providing support for the activity of a PtdCho-PLC. Though the existence of such an enzyme activity has been hypothesized, few studies have examined its regulation, thus it is unclear if it, too, is regulated through the downstream activation of protein kinases.
Role of PtdCho hydrolysis
The hydrolysis catalysed by the three phospholipases generates lipid products that have defined or putative second messenger functions. PI,C activation generates diradylglycerol, which may be diacyl and thus may activate PKC. PLA2 activation generates lysophosphatidylcholine and a non-esterified fatty acid, generally arachidonic acid, that can generate eicosanoids, and in addition has been shown to activate PKC [7] . PLD activation generates phosphatidic acid; initially it was considered that this lipid was converted to DAG by the action of phosphatidic-acid phosphohydrolase, and thus could result in the sustained generation of the activator of PKC. However, cells contain a PtdCho-PIX activity, and so are capable of generating DAG directly from PtdCho rather than requiring two enzymes. There is also increasing evidence that the sustained generation of DAG does not require PLD activation. Inclusion of 30 mM butanol in cell incubations 'traps' the majority of the PID-generated phosphatidyl moieties as the phosphatidylalcohol, since this lipid is not a substrate for the phosphatidate phosphohydrolase, the alcohol will prevent the generation of DAG via a pathway involving PLD. Under such conditions, bombesinstimulated DAG generation is only slightly reduced in Swiss 3T3 cells [8] . Therefore, it is necessary to consider the signalling function of PLD activation as the generation of phosphatidic acid (PA). This then raises the question of the role of PA. A role for PA in CaLf entry was suggested by studies with artificial membrane systems, however, cellular entry has not been confirmed. A number of in vitro functions have been proposed for the lipid, in particular, effects upon the guanine nucleotide state of p21" have been demonstrated. PA has been shown to inhibit the activity of p2 1 "-GTPase-activating protein, and to activate p2 1 "'-GTPase-inhibiting protein. Together these effects, if repeated in vivo, would result in an increase in the life-time of the GTP bound to the p21 protein, and thus maintain the presumed active state (see [ 11) . Other mitogenic functions reported for PA include its direct growth factor action; however, it is now probable that this is due the conversion of PA to LPA. A cell-surface receptor for LPA has been demonstrated by crosslinking studies 191, thus, the effect of the lipid on signalling pathways appear to be mediated through the interaction with an authentic G-protein-linked receptor. A further role for LPA has been suggested by recent studies demonstrating a role in the stimulation of actin stress-fibre formation in fibroblasts, perhaps via an activation of the low-molecular-mass G-protein [ 101. It must be emphasized, however, that there is no evidence at present for the conversion of PI,D-derived PA to LPA. PA has also been demonstrated to inhibit membrane adenylyl cyclase activity, which may also contribute to its mitogenic function [ 13.
PA has been shown to stimulate protein kinase activity. This activation has been demonstrated to be distinct from PKC activity, in that the pattern of phosphorylation in PA-stimulated cell extracts is distinct from that stimulated by DAG under similar conditions. In vitro PKCC is regulated by PA rather than DAG and, since this isozyme is universally expressed, it is possible that the physiological effects of PA, and thus PI,D activation, are mediated through the activation of this kinase.
Therefore, PtdCho hydrolysis generates a number of messenger molecules. As pointed out above, the three phospholipases will not be active necessarily at the same cellular membrane, and they are certainly active at different times. Thus, if these phospholipases are considered together with PtdInsP, hydrolysis, a cell has the capacity for the regulation of function through a range of pathways.
It remains unclear what the individual roles of the pathways are, for example, activation of different PKC isozymes, or indeed which, if any, of these pathways is critical for the transmission of information to the nucleus. It is well-established that the activation of some plasma membrane receptors, such as those for platelet-derived growth factor (PDGF) or bombesin, can lead to the stimulation of the production of the two second messengers: myo-inositol 1,4,5-trisphosphate, a soluble molecule involved in intracellular calcium regulation and diacylglycerol (DAG), a membrane-bound lipid involved in the activation of protein kinase C (PKC) [ l ] . The enzyme phosphoinositidase C (PIC), which is responsible for the phosphodiesteratic cleavage of phosphatidylinositol 4,s-bisphosphate (PIP,), the precursor of the two second messengers, has been found to exist as up to three different families. The y-isoforms appear to be involved in receptor activation through tyrosine-kinase-containing receptors such as PDGF, while the p-isoforms appear to be linked to activation through the G-protein-coupling receptors, such as bombesin, thromboxane, vasopressin and bradykinin. So far, no receptormediated activation of the d-isoform has been demonstrated [2] . Recently, we found that stimulation of a tyrosine-kinase-containing receptor, namely insulin-like growth factor (IGF-1 ), located at the plasma membrane, although unable to activate the phosphatidylinositol (PI) cycle in the plasma membrane could apparently lead to the activation of a similar but distinct PI cycle located within the nucleus.
For In their experiments, they demonstrated that isolated nuclei were able to incorporate "P from radiolabelled ATP into phosphatidylinositol 4-phosphate (PIP), PIP, and phosphatidic acid, suggesting that the lipids PI, PIP and DAG, and also the kinases able to phosphorylate them, were present in the nucleus. Furthermore, Cocco et al.
[ 51 demonstrated that the stimulation of 3T3 cells with IGF-1 could lead to some change in the labelling of PIP during an in vitro kinase assay, described above.
We developed a set of mass assays for PI, PIP, PIP, and DAG that were sensitive enough to be able to measure the mass of these lipids present in isolated nuclei [6] . The results of this study demonstrated that the nuclei of 3T3 cells did indeed contain PI, PIP, PIP, and DAG, and that stimulation of quiescent cells with IGF-1 led to a decrease in the mass levels of PIP and PIP,. Concomitantly with this, we found an increase in the levels of nuclear DAG. A putative downstream effector of this increased nuclear DAG would be PKC, and indeed
by Western blotting we could demonstrate a translocation of PKC to the nucleus. The most obvious interpretation of this is that IGF-1 activates a nuclear PIC activity, which leads to the breakdown of PIP and PIP, to produce DAG within the nucleus, which in turn can be used to activate PKC within this subcellular compartment [6] . Indeed we [7] and others have demonstrated that PIC is present within the nucleus. Moreover, Western blotting experiments demonstrated that only the pl-isoform of PIC was present. As yet it is unresolved whether the changes in the activity of the nuclear PIC reflect changes in the levels of the
